Jonathan Balfour, Panaxium - Precision Bioelectronic Devices | LSI Europe '22

The company's technology aims to make "untreatable" debilitating neurological conditions treatable via the use of precision bioelectronic devices that target specific cellular behaviors at the microscale.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Jonathan Balfour
Jonathan Balfour
CFO/COO, Panaxium